Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties
- 1 July 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 80 (13), 2861-2873
- https://doi.org/10.1158/0008-5472.can-19-3534
Abstract
Although fibrotic stroma forms an integral component of pancreatic diseases, whether fibroblasts programmed by different types of pancreatic diseases are phenotypically distinct remains unknown. Here we show that fibroblasts isolated from patients with pancreatic ductal adenocarcinoma (PDAC), chronic pancreatitis (CP), periampullary tumors (PAT), and adjacent normal (NA) tissue (N=34) have distinct mRNA and miRNA profiles. Compared to NA-fibroblasts, PDAC-associated fibroblasts were generally less sensitive to an anti-fibrotic stimulus (NPPB) and more responsive to positive regulators of activation such as TGFβ1 and WNT. Of the disease-associated fibroblasts examined, PDAC- and CP-derived fibroblasts shared greatest similarity, yet PDAC-associated fibroblasts expressed higher levels of Tenascin C (TNC), a finding attributable to miR-137, a novel regulator of TNC. TNC protein and transcript levels were higher in PDAC tissue versus CP tissue and were associated with greater levels of stromal activation, and conditioned media from TNC-depleted PDAC-associated fibroblasts modestly increased both PDAC cell proliferation and PDAC cell migration, indicating that stromal TNC may have inhibitory effects on PDAC cells. Finally, circulating TNC levels were higher in patients with PDAC compared to CP. Our characterization of pancreatic fibroblast programming as disease-specific has consequences for therapeutic targeting and for the manner in which fibroblasts are used in research.Other Versions
Funding Information
- Pancreatic Cancer Research Fund (M384-F1)
- Pancreatic Cancer UK
- National Institute for Health Research Liverpool Pancreas Biomedical Research
- North West Cancer Research (CR1142)
- Cancer Research UK
- NIHR University College London Hospitals
- Biomedical Research Centre
This publication has 40 references indexed in Scilit:
- Hypoxia-Inducible Factor-1alpha and MAPK Co-Regulate Activation of Hepatic Stellate Cells upon Hypoxia StimulationPLOS ONE, 2013
- The role of inflammatory cells in fostering pancreatic cancer cell growth and invasionFrontiers in Physiology, 2012
- Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosisNature Communications, 2012
- Tenascin-C deficiency attenuates TGF-β-mediated fibrosis following murine lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Role of Pancreatic Stellate Cells in Pancreatic Cancer MetastasisThe American Journal of Pathology, 2010
- Isolation of Quiescent Human Pancreatic Stellate Cells: A Promising in vitro Tool for Studies of Human Pancreatic Stellate Cell BiologyPancreatology, 2010
- Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cellsMolecular Cancer, 2010
- Overexpression of Smoothened Activates the Sonic Hedgehog Signaling Pathway in Pancreatic Cancer–Associated FibroblastsClinical Cancer Research, 2010
- Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptideFEBS Letters, 2009
- The Molecular Basis of Pancreatic FibrosisPancreas, 2004